I
Inherent
Recursively self-improving AI lab for scientific discovery
About Inherent
Inherent (Inherent Labs) is a London Public Benefit Corporation AI lab building Faraday, a system for human-led scientific curiosity combined with recursively self-improving algorithmic exploration — aiming to write a playbook for AI-native science rather than plug AI into traditional methods alone. Co-founders include Tantum Collins, Edward Hughes and Louis Kirsch (DeepMind alumni; Collins also worked on AI policy at the White House under President Biden) and Kaloyan Aleksiev (Reka AI / Microsoft); Matt Clifford advises. Operating as an independent deep-tech research entity, Inherent directs capital to foundational research, compute and human–machine discovery paradigms rather than immediate SaaS monetisation. Emerging from stealth in May 2026, Inherent raised a $50 million seed co-led by Index Ventures and Radical Ventures. Sources: Tech.eu 29 May 2026; inherentlabs.ai.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2025
- Headquarters
- London, United Kingdom
- Open positions
- 5
- Dealroom signal
- 87.2/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Core AI, Novel AI, Generative AI, genAI Model Maker, genAI Applications, AI Model Maker, ai model layer, DT and LS
- Technology
- Artificial Intelligence, Deep Tech
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | May 2026 | $50M | $200M | Radical Ventures · Index Ventures | ↗ |
Growth signals
Latest recorded traffic for Inherent is 4.6K monthly website visits.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 BoltzAI foundation models for computational drug discovery |
London, United Kingdom | Operational | 29 | $28M | $112M |
 Latent LabsWe are making biology programmable to transform health and sustainability for the benefit of all |
London, United Kingdom | Operational | |||
 ProfluentGenerative AI platform designing functional proteins for therapeutics |
Emeryville, United States | Operational | |||
 HarkDeveloping human-centric personal intelligence integrated into custom hardware. |
San Jose, United States | Operational | |||
 MirendilAI models for biology and materials science research |
San Francisco, United States | Operational | |||
 SpAItialAI-powered spatial foundation models for generating 3D environments |
London, United Kingdom | Operational | |||
 WayveMapless, hardware-agnostic AI driving software for OEMs |
London, United Kingdom | Operational | |||
 Generate BiomedicinesPioneering Generative Biology to create breakthrough medicines |
Somerville, United States | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Index Ventures
Radical Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Inherent on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Inherent’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.